Dechra Pharmaceuticals acquires California-based Med-Pharmex for £221.5m

Dechra has acquired Med-Pharmex, Inc, a veterinary pharmaceutical manufacturer based in Pomona, California, for £221.5m.

. Ian Page, chief executive Officer at Dechra commented: “I am delighted that we have completed the acquisition of Med-Pharmex, a company that I have been in dialogue with for a number of years. The US market is highly consolidated, therefore this is a unique opportunity to add several new products to our portfolio, enter the US FAP market and improve the manufacturing footprint for our North American business.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Sony says it believes Xbox owning Call of Duty ‘could influence users’ console choice’ | VGCNew regulatory docs have shown Sony believes Xbox owning Call of Duty 'could influence users’ console choice'. may some remind sony them Money Hating dozen not inhouse IP's away from Xbox? Esp when it comes to japanese devs Final Fantasy is almost non existent on xbox apart from the spin off games that are not that good but the main games and remakes been skipping xbox The regulators listening to Sony whine about COD exclusivity & GamePass. no one gives a shit
Source: VGC_News - 🏆 125. / 51 Read more »